Ivrea is a specialty pharmaceutical company focused on clinical development and commercialization of novel prescription pharmaceuticals for the treatment of dermatologic conditions. Ivrea's initial efforts are focused on the treatment of onychomychosis, acne and photodamage. The company has no perceivable activities since July 2007.